Epic Sciences has added a pair of private equity investors and another strategic investor with its series E round of $52 million. That puts it in an optimal spot for a potential initial public offering and strategic deal-making. The round was led by health care private equity firm Blue Ox Healthcare Partners, with participation by another health care PE group Deerfield Management and cancer radiotherapy company Varian Medical Systems Inc. Read More
